ETF Expert

Read almost any investment book and one of the first terms you are likely to come across is “diversification.” Over the last 6 months, Biotech ETFs have had a low correlation to the S&P 500, meaning that they’ve been great diversifers. They’ve also been rather profitable.

Could Biotech ETFs be just what the doctor ordered? On another topic, could Commodity ETFs be poised for new gains?

Is Biotech The Future Of Healthcare? - Jeff Miller, A Dash Of Insight
Indices, Commodities ETFs Heading Higher - Chris Vermeulen, The Street
ProShares To Roll Out More ‘Geared’ ETFs - Cinthia Murphy, Index Universe

Disclosure Statement: ETF Expert is a web log (”blog”) that makes the world of ETFs easier to understand. Gary Gordon, MS, CFP is the president of Pacific Park Financial, Inc., a Registered Investment Adviser with the SEC. The company and/or its clients may hold positions in the ETFs, mutual funds and/or index funds mentioned above. The company does not receive compensation from any of the fund providers covered in this feature. Moreover, the commentary does not constitute individualized investment advice. The opinions offered herein are not personalized recommendations to buy, sell or hold securities. Investors who are interested in money management services may visit the Pacific Park Financial, Inc. web site.

Tags | Biotech ETFs, Commodity ETFs, Leveraged ETFs